A chemoenzymatic total synthesis of (+)-amabiline.

Org Lett

Research School of Chemistry, Institute of Advanced Studies, The Australian National University, Canberra, ACT 0200, Australia.

Published: July 2009

The readily available and enzymatically derived cis-1,2-dihydrocatechol 3 has been converted, over 15 steps, into (+)-amabiline, the non-natural enantiomeric form of a crinine-type alkaloid.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ol901230wDOI Listing

Publication Analysis

Top Keywords

chemoenzymatic total
4
total synthesis
4
synthesis +-amabiline
4
+-amabiline enzymatically
4
enzymatically derived
4
derived cis-12-dihydrocatechol
4
cis-12-dihydrocatechol converted
4
converted steps
4
steps +-amabiline
4
+-amabiline non-natural
4

Similar Publications

Polycyclic tetramate macrolactams (PoTeMs) represent a growing class of bioactive natural products that are derived from a common tetramate polyene precursor, lysobacterene A, produced by an unusual bacterial iterative polyketide synthase (PKS) / non-ribosomal peptide synthetase (NRPS). The structural and functional diversity of PoTeMs is biosynthetically elaborated from lysobacterene A by pathway-specific cyclizing and modifying enzymes. This results in diverse core structure decoration and cyclization patterns.

View Article and Find Full Text PDF

Drimane-type merosesquiterpenoids (DMT) are a class of natural products with diverse structures and broad biological activity. Classical DMT synthesis relies on atom-inefficient plant-derived chiral pool building blocks, while alternative drimane-type building blocks such as drimenol and albicanol offer more direct routes but face production challenges. In this study, we engineered a microbial platform for efficient production of these building blocks.

View Article and Find Full Text PDF

This report describes the asymmetric synthesis of a focused library of enantiopure structured triacylglycerols (TAGs) comprised of a single saturated fatty acid (C6, C8, C10, C12, C14 or C16), a pure bioactive n-3 polyunsaturated fatty acid (EPA or DHA) and a potent drug (ibuprofen or naproxen) intended as a novel type of prodrug. One of the terminal -1 or -3 positions of the glycerol backbone is occupied with a saturated fatty, the remaining one with a PUFA, and the drug entity is present in the -2 position. This was accomplished by a six-step chemoenzymatic approach starting from enantiopure ()- and ()-solketals.

View Article and Find Full Text PDF

Scalable Protecting-Group-Free Total Synthesis of Resibufogenin and Bufalin.

Org Lett

November 2024

The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Article Synopsis
  • - A new method for synthesizing resibufogenin and bufalin was developed using only seven steps without the need for protecting groups, starting from androstenedione (AD).
  • - The synthesis involved introducing a hydroxyl group at C14 using hydroxylase P-450, which helped control the configuration at C17 during subsequent reactions.
  • - The final steps included dehydrating the intermediate and using epoxidation to produce resibufogenin, while bufalin was synthesized through a more complex anaerobic Mukaiyama hydration process.
View Article and Find Full Text PDF

The chemical synthesis of -acyl indoles is hindered by the poor nucleophilicity of indolic nitrogen, necessitating the use of strongly basic reaction conditions that encumber elaboration of highly functionalized scaffolds. Herein, we describe the total chemoenzymatic synthesis of the bulbiferamide natural products by the biochemical activity reconstitution of a nonribosomal peptide synthetase assembly line-derived (NRPS-derived) thioesterase that neatly installs the macrocyclizing indolylamide. The enzyme represents a starting point for biocatalytic access to macrocyclic indolylamide peptides and natural products.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!